期刊文献+

第011例 乙肝肝硬化核苷(酸)类似物相关多重耐药突变1例分析

下载PDF
导出
摘要 1病例资料 患者,女性,58岁。1980年查体发现乙肝病毒表面抗原(HBsAg)阳性,肝功正常,未进一步诊疗和复查。于1986年出现肝功反复异常[丙氨酸氨基转移酶(ALT)57~106 U/L],间断保肝治疗,效果欠佳。于2004年5月B超检查提示:肝硬化、脾大,给予拉米夫定(LAM)100 mg/d抗病毒治疗,此时ALT 69 U/L,HBsAg、乙型肝炎e抗原(HBeAg)和抗。
作者 杨芳 王磊
出处 《中国医学前沿杂志(电子版)》 2011年第1期87-88,共2页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
  • 相关文献

参考文献3

二级参考文献26

  • 1Bartholomeusz A, Locarnini SA. Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis, 2006, 26: 162-170.
  • 2Tenney DJ, Levine SM, Rose RE, et al. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother, 2004, 48: 3498-3507.
  • 3Pawlotsky JM, Dusheiko G, Hatzakis A, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology, 2008, 134: 405-415.
  • 4Lai CL, Gane E, Hsu CW, et al. Two-year results from the GLOBE trial in patients with hepatitis B: greater clinical and antiviral efficacy for telbivudine (LdT) vs lamivudine. Hepatology, 2006, 44 (Suppl 1): 222A.
  • 5Lau GK, Piratvisuth T, Luo KX, et al. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med, 2005, 352: 2682-2695.
  • 6Marcellin P, Lau GK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med, 2004, 351: 1206-1217.
  • 7Sung JY, Lai JY, Zeuzem S, et al. A randomized double-blind phase Ⅱ study of lamivudine compared to lamivudine plus adefovir dipivoxil for treatment naive patients with chronic hepatitis B: week 52 analysis. J Hepatol, 2003: 38(suppl 2): 25-26.
  • 8Lai CL, Leung N, Teo EK, et al. A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology, 2005, 129: 528- 536.
  • 9Locarnini S, Mason WS. Cellular and virological mechanisms of HBV drug resistance. J Hepatol, 2006, 44: 422-431.
  • 10Lok AS, Zoulim F, Locarnini S, et al. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology, 2007, 46: 254-265.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部